We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
That was a large sell at then end of play...
Let's hope a little RNS pops up on Monday !!!!
I hear you dhub.
Ive transferred my children's Trust Funds to junior ISAs so we could purchase more.
I have guaranteed their initial stake but I'm cautiously optimistic they will have that back this year and then they will enjoy a free HEMO trip.
we would of course like a decent return but it also helps their interest that these candidates are potentially transformative for people with awful illness. but for the grace of god...
best wishes holders
One of trades classified as " unknown" is a Buy from me as well.
So the 599k and the 500k are both buys, but marked as sells. I personally think we got a bargain Hemotruth :) Time will tell
Hi JHFH,
Thanks for your comments, very much appreciated.
Interesting that both IQAI and HEMO are operationally at their most advanced and yet their SP’s and many others that I follow are near their nadir.
I was fortunate enough to hold both HZD and LID when they were taken over last year. Both appreciated in value on takeover albeit HZD was imo disappointing. I strongly believe there is an appetite for these type of stocks once they reach an inflexion point and it’s their alliances that can make the difference; that’s a strength for HEMO and the likes of ONC. Perhaps though nowhere more evident than at SAR where both operational excellence and financial support has transformed the SP.
I am not going to bore posters with the financial shortcomings of here or IQAI or DDDD, AVCT, POLX or others that I have traded for that matter. Suffice to say it’s my opinion that the market handsomely rewards operational excellence when a clear financial pathway is also in plain sight.
However, one can’t have it all ways, ops, finance and cheap! You have to pay more for both. Much more!
When those pathways become crystal clear to the market then the SP(s) will significantly rerate. Not just a brief wander into 2’s and back!
Hi Hemotruth,
Yes I didn’t think it was a rerate, as above, that’s why I bought some more. What am I missing? I also hope we will see 1.5 again so I can reach my target.
I hope to do well on my SNG trade that closes today from a buy yesterday. Then I will buy more HEMO hoping for lower but if it goes higher all the better!
If my posts make absolutely any difference to the volumes needed to shift the sp then I would be amazed! Lol!
I hold a core and trade a few to keep my average and take a little profit. Too many war wounds!
Good luck with your investments,
Usual caveats
Trader Trek! Lol!
Hey MrIndia, I know your under pressure as I think you said recently you had to sell? Maybe I misuderstood, either way look at it this way:
You have a house, you bought it with your wife and you are now divorced, you have to sell the house before you can move as neither has enough cash to buy or rent elsewhere. You have viewings every other day and when people arrive you and your wife make it perfectly clear you HAVE to sell. She likes to point out the tiles you broke in the kitchen, she likes to point out the mould you never cleaned. Each time the buyers run away and the estate agent drops the price and you and your wife blame each other and want to kill each other more. Its not the houses fault people are not buying... Put a kettle with fresh coffee on the stove, shut up, both of you buger off out of the house and let the estate agent do the viewing.
There is so little talk or chatter about hemo that you make up a significant part of all humanity talking about Hemo and everything you say is negative. If you actually want the SP to go up post some useful constructive posts, go and create a twitter account and talk about hemo. I am not trying to attack you but you have to see that what you keep doing is counter productive but you could instead try and help the situation.
Hemo is an absolute bargain, they are making incredible progress and I am very confident in them, but the SP sucks monkey balls. Let Vlad get on with getting us to clinical trials and at some point we will re-rate and we will all be rewarded! :-)
The 599,173 is a buy...I can guarantee that !!
Bline59 .... I would sell if i could but i am 60k down so just stock here.
Well I've taken advantage of this low price for a top up. I haven't lost faith
28 Jan 2022 BUY HEMO LSE 500,000 1.62p £8,170.10
Mr India. Here is an Investment true example for you....I have half a dozen like this;
I am also in Avacta bought in at 37p years ago.
Today they are £1.00 as I write this this message.
( You would no doubt have sold at 50p if you had bought at 37p).
Full trials are not expected until Q4 2023 and results into 2024.
SP potential is huge...I mean huge with a capital H....(£20 is a realistic minimum)
I hold like other investors.
HEMO is the on the same path with possibly similar timescales, but the potential is even bigger with capital HU of huge.
Investing is a 3 years plus scenario.
Lloyds Bank, BAE Systems, have been 20 years plus for me but I hold for the Dividends etc as with the others.
Honestly mate, get a investment strategy with either an exit date/figure whatever, or a long term hold.
You seem to be more of a BET FRED customer mentality with micro managing the SP every 18 seconds.
I don't believe Buffett and co give running commentaries only quarterly updates....there is a message there amigo.
I honestly dont care what you think and you can assume i am deramping or whatever. I am just a frustrated investor and entitled after watching this stock but I also know thats my fault. Call me what you like but whether it is 1 or 2 weeks or longer, I still don't undestand why people would sell rather than just wait for a short period of time. I saw another 1M sell yesterday so people are losing faith here and believe they can make money elsewhere.
BTW, whatever i say will NOT influence anyone if you are a firm believer but I am just expressing my issues with this stock after holding for over 18 months (not 18 minutes !!!)
I'm trying to remember the lowest price I've seen this at. I think the bid was 1.45 and the ask 1.60 (others may correct me if I'm wrong), so we are pretty darn close to that. I'm sure we won't go lower than that as 1.5p was the placing price? Anyway, looking at the positives, it's a very good price for a buying opportunity. Surely the upside is far greater than the downside. Lets just hope the RNS comes out next week re the FDA
@MrIndia I have simply quoted from the FDA and their guidance is 60 days, not 5 minutes or 1 hour. Every time its red you are posting about how there has been no news in the whole 5 minutes from your last post. I have said before pharma is clearly not for you. 60 days is 60 days, we have another 2 weeks before that 60 days is up and even after that it could be days or weeks before an update. Likewise it could come before then, there could be an update on Monday for all any of us know.
"I think next week we could see alot of people leaving" - Either your serious and therefore an idiot or your intentionally attempting to deramp and I return to my previous assumption about you.
Thanks Brewsky.
I was just at a loose end (got bored there with my paid work)...appreciate it will come when it comes and I have no doubt it will.
Good Luck to you and all.
No one is buying. I dont think people think any news is coming soon and people are just selling. Everyone keeps saying be patient but it doesnt make sense why if news was really imminent, why wouldnt you just wait till next week.
I think next week we could see alot of people leaving if news doesnt come and Brewsky states, Vlad doesnt care about PIs. He never has and never will. We just have to hope there is positive items soon ...
@Chris0123 dont over think it, Dr Sander does not plan RNS's to have maximum effect on the market (unfortunately). It is a coincidence and says more about how businesses operate and Friday in particular is a non productive workday. I agree though, today is probably a better buying day than Monday as we have now had no update on CBR for months and CAR-T PIND could happen any day.
In reviewing the last 8 RNS's development announcements(excluding Price Monitoring), since Wednesday 2nd June; these were announced on the following days:
3 on a Wednesday
1 on a Thursday
4 on a Monday
Not scientific, but where they can be held back without breach of regulations - today is very unlikely; Monday looks great with a clear 2nd favourite on Wednesday. Could today be the calm before weather breaks on Monday??!! As I say not a scientific sample but just under half the number that might be involved in Hemo Clinical trials. Today probably a better buying day than Monday. Best of luck all, stay onboard.
Good morning Trek, thank you for your response, I went back and read more about IQAI, I think its fantastic what they are doing and the potential of the software to allow cross site comparison could make a huge difference. In addition the removal of heavy metals from the body is always a good thing. I say this here and not on the IQAI as its likely this would come across as de-ramping over there:
The tests in question fall under:
70551 MRI Brain w/o Cont $664 $863 $1,328
Any new software or different pills will be coming out of a pretty small budget and its not a disruptor to the market as Gadolinium is only used in 1 out of 3 scans today anyway. For me its the reliability of IA over humans, being able to compare scans from different machines and the fact it opens up scans to people at risk of NSF and young children that make it attractive. But in the private hospitals it will come down to how much it reduces costs and increases throughput, environmental concerns wont make any difference.
So sounds good, but in terms of profit margin and potential etc you have to remember that its a diagnostic expense and an average scan is not that much, it will have a limiting effect on how much hospitals will pay. For me the sensible option for them would be to approach some of the big suppliers of medical equipment and make this some sort of integrated installation delivered as standard with new MRI machines and upgrades.
When I compare that with a clinical trial for CAR-T and Hemo, here you have a disruptor, there is no CAR-T treatment for AML, there is no effective non toxic cure. Its not a bolt on or improvement to an existing service. CAR-T also has the benefit of being new and in the media attention. Then the cost, in August 2020 estimated that the total cost of treatment with Kymriah for ALL patients was $612,779 and its likely that Medicare will pay for CAR-T (Probably not as much in future though). This is the drug that Penn brought to market, the same Penn working with Hemo on HEMO-CAR-T. In the US 11,400 deaths are reported of AML each year, how many of those would Hemo have to treat charging only £250k a fraction of what others charge to cover their mCap? 60-70 patients? They are doing 20 (probably for free as part of Phase 1 trials)
IQAI have an mCap of £11mil, they look like they have something that should be a standard, but with approx 11,900 MRI systems in the US how many will use IQAI? how much can IQAI charge per site per unit? MRI service costs 2-10k per month how much extra can IQAI expect a hospital to pay in subscription fees?
I dont want this to sound negative, I just want to highlight that IQAI is relatively low risk, sounds like it works, could turn a good revenue and pay a dividend and not a bad idea to add to PF as a safer play. On the flip, Hemo is much higher risk but a much larger market and potential.
I agree about the IQAI board, where is Nolupus he has gone very quite on most of the boards he participated on. Like yourself he could be very informative without ramping.
Spot on HRH........it's coming mate, it's coming.
After wobbling a bit of late I thought I’d go through all the RNS’s and Vlads interviews last night to reaffirm to myself why I invested. I must say it’s got me very bullish of the stock again. For Vlad to be moving into such a big laboratory in a couple of months, with the capability to make their own CAR demonstrates a high degree of internal confidence in HEMO CAR-T and SAFE CAR-T, especially knowing how frugal Vlad is in spending money. I understand HEMO are going to discuss fast tracking this candidate into clinical trials although not sure as yet whether it’ll be assigned as a breakthrough therapy but either way I expect it to move quickly into trials after the IND application. Upon application I think volume will return and we’ll start the long road back up, after all it’s potentially a billion dollar candidate. Add in CBR and a CDX update it must be a profitable couple of quarters for holders, in my opinion anyway. I’m now comfortable again, holding and waiting. Tick tock.
First trade was cancelled or spoofed! It’s 1.6849 to buy 100k. I added a few.
Re IQAI, I don’t want to over discuss JHFH, just read the shareholder update last RNS it will explain what the 2nd IND was for and the clinical trial.
My intention was to show that IND approval (their first one) doesn’t necessarily mean a rerate. In the case of HEMO such is the anticipation and the magnitude of the tech it may well do. But no guarantees.
Happy to take questions on IQAI bb, gosh it could do with some posts!
Usual caveats,
Trek
Pumpkin it just looks like that, go look on London Stock Exchange and you will see its just 2 entries, one trade one cancellation. Idk, maybe wrong ticker or something, its a nothing berger.
Let's hope it's Mr depressing !
Sold/ cancelled then sold again?